EQL Pharma to Publish Q1 Report and Hold Investor Presentation
EQL Pharma AB (publ) will publish its interim report for the first quarter of 2026/27 on Friday, August 7. The company will subsequently hold a presentation for shareholders and potential investors.
EQL Pharma AB (publ) is scheduled to release its interim report for the first quarter of the 2026/27 fiscal year on Friday, August 7. Following the report's publication, the company will host a presentation via video conference.
CEO and President Axel Schörling will lead the presentation, offering commentary on the interim report's findings. The session is designed for both existing shareholders and prospective investors. A question-and-answer period will follow Schörling's remarks.
Interested parties can access the virtual meeting through the provided link.
Link to virtual meeting: https://tinyurl.com/nj5tmxzh
The presentation is scheduled for August 7, 2026, at 10:00 AM CET.